Atlas Trials

Comparative Clinical Study Between Empagliflozin Versus Pioglitazone in Non-diabetic Patients With Non-alcoholic Steatohepatitis

Clinical trial NCT05605158 · UNKNOWN

Trial details

NCT number
NCT05605158
Sponsor
Tanta University
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Non Alcoholic Steatohepatitis
Start date
2022-11-01
Primary completion
2023-05-01
Enrollment
56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.